Literature DB >> 21346234

Decreased thymic output accounts for decreased naive T cell numbers in children with Down syndrome.

Beatrijs L P Bloemers1, Louis Bont, Roel A de Weger, Sigrid A Otto, Jose A Borghans, Kiki Tesselaar.   

Abstract

Children with Down syndrome (DS) have low numbers of naive T cells and abnormal thymus development and function. Because next to thymic production, peripheral proliferation greatly contributes to naive T cell generation in healthy children, we examined the cause of reduced naive T cell numbers in children with DS. Compared with aged matched controls, the total number of signal joint TCR excision circles (sjTREC) per ml blood was reduced in DS. Reduced frequencies and absolute numbers of protein tyrosine kinase 7-positive recent thymic emigrants, but similar levels of naive T cell apoptosis and Ag-driven activation in DS, suggested that reduced thymic output and not increased peripheral loss of naive T cells caused the reduced sjTREC numbers. We found no support for defective peripheral generation of naive T cells in DS. In DS the naive T cells responded to IL-7 and, based on Ki-67 expression, had similar proliferation rates as in healthy controls. sjTREC content per naive CD8(+) T cells was not increased, but even decreased, pointing to increased survival or peripheral generation of naive T cells in DS. In conclusion, we show in this study that reduced thymic output, but not reduced peripheral generation nor increased loss of naive T cells, results in the low naive T cell numbers found in DS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21346234     DOI: 10.4049/jimmunol.1001700

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Defective thymic progenitor development and mature T-cell responses in a mouse model for Down syndrome.

Authors:  Laureanne P E Lorenzo; Kristen E Shatynski; Sarah Clark; Paul J Yarowsky; Mark S Williams
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

2.  Heart Transplantation in Children With Down Syndrome.

Authors:  Justin Godown; Darlene Fountain; Neha Bansal; Rebecca Ameduri; Susan Anderson; Gary Beasley; Danielle Burstein; Kenneth Knecht; Kimberly Molina; Sherry Pye; Marc Richmond; Joseph A Spinner; Kae Watanabe; Shawn West; Zdenka Reinhardt; Janet Scheel; Simon Urschel; Chet Villa; Seth A Hollander
Journal:  J Am Heart Assoc       Date:  2022-05-16       Impact factor: 6.106

3.  Deep immune phenotyping reveals similarities between aging, Down syndrome, and autoimmunity.

Authors:  Katharina Lambert; Keagan G Moo; Azlann Arnett; Gautam Goel; Alex Hu; Kaitlin J Flynn; Cate Speake; Alice E Wiedeman; Vivian H Gersuk; Peter S Linsley; Carla J Greenbaum; S Alice Long; Rebecca Partridge; Jane H Buckner; Bernard Khor
Journal:  Sci Transl Med       Date:  2022-01-12       Impact factor: 19.319

4.  Down syndrome, autoimmunity and T regulatory cells.

Authors:  F P Pellegrini; M Marinoni; V Frangione; A Tedeschi; V Gandini; F Ciglia; L Mortara; R S Accolla; L Nespoli
Journal:  Clin Exp Immunol       Date:  2012-09       Impact factor: 4.330

5.  Local bone-marrow exposure: how to interpret the data on stable chromosome aberrations in circulating lymphocytes? (some comments on the use of FISH method for dose reconstruction for Techa riverside Residents).

Authors:  Evgenia I Tolstykh; Marina O Degteva; Alexandra V Vozilova; Lynn R Anspaugh
Journal:  Radiat Environ Biophys       Date:  2017-09-09       Impact factor: 1.925

6.  Maraviroc Intensification of cART in Patients with Suboptimal Immunological Recovery: A 48-Week, Placebo-Controlled Randomized Trial.

Authors:  Steven F L van Lelyveld; Julia Drylewicz; Maaike Krikke; Ellen M Veel; Sigrid A Otto; Clemens Richter; Robin Soetekouw; Jan M Prins; Kees Brinkman; Jan Willem Mulder; Frank Kroon; Ananja Middel; Jori Symons; Annemarie M J Wensing; Monique Nijhuis; José A M Borghans; Kiki Tesselaar; Andy I M Hoepelman
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

7.  Premature Senescence and Increased Oxidative Stress in the Thymus of Down Syndrome Patients.

Authors:  Genni Enza Marcovecchio; Francesca Ferrua; Elena Fontana; Stefano Beretta; Marco Genua; Ileana Bortolomai; Anastasia Conti; Davide Montin; Maria Teresa Cascarano; Sonia Bergante; Veronica D'Oria; Alessandro Giamberti; Donato Amodio; Caterina Cancrini; Adriano Carotti; Raffaella Di Micco; Ivan Merelli; Marita Bosticardo; Anna Villa
Journal:  Front Immunol       Date:  2021-06-01       Impact factor: 7.561

8.  Modular transcriptional repertoire and MicroRNA target analyses characterize genomic dysregulation in the thymus of Down syndrome infants.

Authors:  Carlos Alberto Moreira-Filho; Silvia Yumi Bando; Fernanda Bernardi Bertonha; Filipi Nascimento Silva; Luciano da Fontoura Costa; Leandro Rodrigues Ferreira; Glaucio Furlanetto; Paulo Chacur; Maria Claudia Nogueira Zerbini; Magda Carneiro-Sampaio
Journal:  Oncotarget       Date:  2016-02-16

9.  Differential Expression of Inflammation-Related Genes in Children with Down Syndrome.

Authors:  Cláudia Regina Santos Silva; Joice Matos Biselli-Périco; Bruna Lancia Zampieri; Wilson Araujo Silva; Jorge Estefano Santana de Souza; Matheus Carvalho Bürger; Eny Maria Goloni-Bertollo; Érika Cristina Pavarino
Journal:  Mediators Inflamm       Date:  2016-05-11       Impact factor: 4.711

10.  Impact of Aging, Cytomegalovirus Infection, and Long-Term Treatment for Human Immunodeficiency Virus on CD8+ T-Cell Subsets.

Authors:  Ellen Veel; Liset Westera; Rogier van Gent; Louis Bont; Sigrid Otto; Bram Ruijsink; Huib H Rabouw; Tania Mudrikova; Annemarie Wensing; Andy I M Hoepelman; José A M Borghans; Kiki Tesselaar
Journal:  Front Immunol       Date:  2018-03-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.